Understanding the Clinical Significance of Cytomegalovirus Viremia After Chimeric Antigen Receptor T-Cell Therapy: Should We be Treating a Value?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Understanding the Clinical Significance of Cytomegalovirus Viremia After Chimeric Antigen Receptor T-Cell Therapy: Should We be Treating a Value?

Published:2024-02-02 Issue: Volume: Page:
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Kampouri Eleftheria¹²^ORCID,Boeckh Michael J¹³⁴,Hill Joshua A¹³⁴

Affiliation:

1. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center , Seattle, Washington , USA

2. Infectious Diseases Service , Lausanne University Hospital and University of Lausanne, Lausanne , Switzerland

3. Clinical Research Division, Fred Hutchinson Cancer Center , Seattle, Washington , USA

4. Department of Medicine, University of Washington , Seattle, Washington , USA

Funder

Swiss National Science Foundation

SICPA Foundation

National Institutes of Health

Merck

Oxford Immunotec

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae030/56812481/ciae030.pdf

Reference10 articles.

1. CMV viral load kinetics as surrogate endpoints after allogeneic transplantation;Duke;J Clin Invest,2021

2. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation;Marty;N Engl J Med,2017

3. CMV reactivation and CMV-specific cell-mediated immunity after chimeric antigen receptor T-cell therapy;Kampouri;Clin Infect Dis,2023

4. Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant;Chen;Haematologica,2023

5. Impact of cytomegalovirus replication in patients with aggressive B cell lymphoma treated with chimeric antigen receptor T cell therapy;Márquez-Algaba;Transplant Cell Ther,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy;Blood Advances;2024-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3